Author

Evelien Kruisselbrink

Utrecht University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Annelotte M. VonkiD· 1 shared Antoni R. BlaazeriD· 1 shared Cornelis Korstiaan van der EntiD· 1 shared Edward DompelingiD· 1 shared Els J.M. WeersinkiD· 1 shared Eyleen de Poel· 1 shared Georgia N. Ithakisiou· 1 shared Gerard H. KoppelmaniD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Annelotte M. VonkORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Molecular BiologyJournal of Cystic FibrosisPeer-reviewedMay 1, 2023

FDA-Approved Drug Screening in Patient-Derived Organoids Demonstrates Potential of Drug Repurposing for Rare Cystic Fibrosis Genotypes

Eyleen de Poel, Sacha Spelier, Marne C. Hagemeijer…·Jeffrey Matthijn Beekman

The paper screens 1400 FDA-approved drugs in CF patient-derived intestinal organoids using a functional assay to identify potential repurposing for rare CF genotypes.

44 citationstop 2%

humanexperimental assay

𝕏 PostBluesky